PET scan for meningioma radiation planning
Part of Brain & nervous system, Cancer clinical trials.
This trial uses a special PET scan (DOTATATE) to help plan radiation treatment for meningioma, a type of brain tumor. It aims to make radiation more precise, possibly reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have meningioma that needs radiation, either as main treatment or after surgery
- You have not had radiation or drug treatment for this tumor before
- You are not pregnant or breastfeeding
- You can lie still for the scan and do not have severe claustrophobia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan to find active tumor areas and then delivers a stronger dose of radiation to those spots. It is for people with aggressive or returning meningiomas who have not had brain radiation before.
This trial tests a special imaging agent called [Cu64]DOTATATE that helps surgeons see meningioma tumors during surgery. It may make tumor removal more complete and safer.
This trial tests how well a special scan (Ga-68 DOTATATE PET combined with MRI) helps diagnose and guide treatment for certain brain tumors that have somatostatin receptors. It may help doctors better find tumor recurrence or remaining tumor after treatment.
This study uses a special PET scan to see if a protein called PSMA is present on recurrent meningiomas. The results will help plan a future treatment that targets this protein with radioactive medicine.
This trial tests a type of radiation (protons) for brain tumors called atypical or anaplastic meningiomas that need radiotherapy. It may help by aiming radiation more precisely while also learning the safest and most effective dose.
This trial tests a new type of MRI scan that may help see meningioma brain tumors more clearly. It is a short imaging study for people who plan to have surgery or monitoring.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.